Clinical management of hepatic malignancies: ferucarbotran-enhanced magnetic resonance imaging versus contrast-enhanced spiral computed tomography
Contributeurs/tricesLencioni, Riccardo; Della Pina, Clotilde; Bruix, Jordi; Majno, Pietro; Grazioli, Luigi; Morana, Giovanni; Filippone, Antonella; Laghi, Andrea; Bartolozzi, Carlo
Publié dansDigestive diseases and sciences, vol. 50, no. 3, p. 533-537
Date de publication2005
Résumé
Mots-clés
- Adult
- Aged
- Aged, 80 and over
- Carcinoma, Hepatocellular/diagnosis/mortality/therapy
- Combined Modality Therapy
- Contrast Media
- Dextrans
- Female
- Ferrosoferric Oxide
- Humans
- Iron/diagnostic use
- Liver Neoplasms/diagnosis/mortality/therapy
- Magnetic Resonance Imaging/methods
- Magnetite Nanoparticles
- Male
- Middle Aged
- Oxides/diagnostic use
- Prognosis
- Prospective Studies
- Radiographic Image Enhancement
- Risk Assessment
- Sensitivity and Specificity
- Survival Rate
- Tomography, Spiral Computed/methods
- Treatment Outcome
Structure d'affiliation
Groupe de recherche
Citation (format ISO)
LENCIONI, Riccardo et al. Clinical management of hepatic malignancies: ferucarbotran-enhanced magnetic resonance imaging versus contrast-enhanced spiral computed tomography. In: Digestive diseases and sciences, 2005, vol. 50, n° 3, p. 533–537.
Fichiers principaux (1)
Article (Published version)
Identifiants
- PID : unige:37077
- PMID : 15810637
ISSN du journal0163-2116